Sort
48,018 grants matching “immunotherapy”
Novel Interventions Against HPV-associated Neoplasia
$762,506Paul F Lambert · University Of Wisconsin-Madison · U01 · FY2011 · CA
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
$762,411Robert L Ferris · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DE
The role of the innate immune system on Treg reprogramming in human autoimmune di
$762,141David A. Hafler · Yale University · U01 · FY2014 · AI
A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies
$762,081Ryan Gessner · Sonovol, Inc. · R44 · FY2022 · CA
T cell homing to the kidney contributes to salt retention and blood pressure regulation
$761,943Shengyu Mu · Univ Of Arkansas For Med Scis · R01 · FY2025 · HL
T cell homing to the kidney contributes to salt retention and blood pressure regulation
$761,943Shengyu Mu · Univ Of Arkansas For Med Scis · R01 · FY2024 · HL
Role of gamma/delta T cells in Vaccine Induced Immunity
$761,813Daniel F. Hoft · Saint Louis University · R01 · FY2018 · AI
New approach for immune modulation against T1D
$761,809Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2023 · DK
Immunotherapeutics Against Other Filovirus Threats
$761,804Jonathan R. Lai · Scripps Research Institute, The · U19 · FY2017 · AI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
$761,749Andrew Sikora · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · DE
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
$761,616Lyle L Moldawer · University Of Florida · R01 · FY2021 · GM
A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)
$761,450Andrew B Norman · University Of Cincinnati · DP1 · FY2012 · DA
A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)
$761,450Andrew B Norman · University Of Cincinnati · DP1 · FY2014 · DA
A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)
$761,450Andrew B Norman · University Of Cincinnati · DP1 · FY2011 · DA
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
$761,409Evan Alexander Scott · Northwestern University · R01 · FY2021 · AI
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
$761,409Evan Alexander Scott · Northwestern University · R01 · FY2022 · AI
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$761,196Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2019 · AI
T CELL AUTOIMMUNITY
$761,172Washington University · P01 · FY2002 · AI
Mechanistic Virology Core
$761,167Kartik Chandran · Scripps Research Institute, The · U19 · FY2014 · AI
Southern Nevada Cancer Research Foundation--CCOP
$761,131Southern Nevada Cancer Research Fdn · U10 · FY2004 · CA
Developing a novel agonist of CD137 for cancer immunoprevention
$761,094Haval Shirwan · University Of Missouri-Columbia · UG3 · FY2024 · CA
Developing a novel agonist of CD137 for cancer immunoprevention
$761,094Haval Shirwan · University Of Missouri-Columbia · UG3 · FY2025 · CA
COMBINATORIAL EPIGENETIC-BASED APPROACH TO ENHANCE OVARIAN CANCER IMMUNOTHERAPY
$761,057Brigham & Womens Hospital Inc · · FY2020 · Defense Health Agency
Translating cellular immunotherapies for autoimmunity to canine clinical trials
$760,992Aimee S Payne · University Of Pennsylvania · R01 · FY2019 · AR
Harnessing adaptive NK cell transfer to deplete viral reservoirs
$760,984David T Evans · University Of Wisconsin-Madison · R01 · FY2024 · AI